Effectiveness of omalizumab in severe persistent asthma under real-life conditions. - Wikidata - awgldk - TriplyDB

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

http://www.wikidata.org/entity/Q33894739

about

Omalizumab Improves Quality of Life and Asthma Control in Chinese Patients With Moderate to Severe Asthma: A Randomized Phase III Study.

P2860

Q40889826-DE95D3AF-AA0E-46F2-BC98-DD390E9A8F25

P2860

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

http://www.wikidata.org/entity/Q33894739

description

2014 nî lūn-bûn

@nan

2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@ast

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@en

type

label

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@ast

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@en

prefLabel

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@ast

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@en

P1433

Q33894739-D778D445-0C72-4B53-8D5B-C6EF69D68CF2

P1476

Q33894739-3AD2E651-FD88-4CEE-8909-B7E804B93035

P2093

Q33894739-8C15128F-88D2-427E-BDF0-5DBC850A20DC

Q33894739-D8D4AA82-5C82-4325-8B00-CB2D1BFDD488

P2860

Q33894739-09D96A3A-621A-45F6-A766-0A6F3C6D6BE3

Q33894739-2CFAC7EA-B336-488B-BA50-FE75522E4501

Q33894739-31D595B6-9717-4A80-8387-D5C06C671535

Q33894739-4E3B5F3C-5933-448E-9D52-C989226D905F

Q33894739-77BAF9C6-CFB7-4DCB-89BD-D5B553B39472

Q33894739-9F3779C0-205F-4CA2-9B54-50B8164BC370

Q33894739-D60C7CA8-4C54-45C6-AC23-B9E567EF2DE2

P304

Q33894739-1505F6C6-AD73-4F64-B223-ADB02B2DB321

P31

Q33894739-ADECE367-0D9D-4195-B1EB-DB0899B97381

P407

Q33894739-A4D48144-6FA2-4F31-80F1-8324A84D894D

P433

Q33894739-C601F73C-BED8-4C02-B2C7-B95483ABB860

P478

Q33894739-E7AB1417-546B-4221-9804-BC11384E0AAC

P577

Q33894739-6979A79A-447E-4DFA-BFF5-1A0ED2C15506

P698

Q33894739-0FB24652-8039-4279-94B6-B187295DA58C

P932

Q33894739-3B9039B8-E9FA-4A45-84A3-5656D773D219

P1433

Canadian Family Physician

P1476

Effectiveness of omalizumab in severe persistent asthma under real-life conditions.

@en

P2093

Anthony D D'Urzo

http://www.w3.org/2001/XMLSchema#string

Jenny Wong

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials

Canadian Thoracic Society Asthma Management Continuum--2010 Consensus Summary for children six years of age and over, and adults.

Global strategy for asthma management and prevention: GINA executive summary.

Efficacy and safety of a recombinant anti-immunoglobulin E antibody (omalizumab) in severe allergic asthma.

Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.

"Real-life" effectiveness of omalizumab in patients with severe persistent allergic asthma: The PERSIST study.

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

P304

643-645

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2014-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25022639

http://www.w3.org/2001/XMLSchema#string

P932

4096265

http://www.w3.org/2001/XMLSchema#string